The next scheduled catalyst is earnings: Hims plans to report Q4 and full-year 2025 results after the close on February 23, 2026, followed by a conference call
While industry funding may introduce potential bias, the trial was well-designed, had a large sample size and transparently reported
Cellular Regeneration Research: Supports studies exploring cellular proliferation, regeneration pathways, and tissue growth models in controlled laboratory environments
See if You Qualify The Zepbound Blindness Lawsuit is an active lawsuit See If You Qualify Lawsuits are currently being filed against the manufacturer of Zepbound, alleging that the medication can cause vision problems such as vision loss, blurry vision, and blindness
You need to learn about your nutrition, what your body needs and how to make a lifestyle change. Advertisement Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more